ID   NAGK_HUMAN              Reviewed;         344 AA.
AC   Q9UJ70; B4DLZ5; Q53HD5; Q6IA84; Q9BS29; Q9BVP0; Q9NV37;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   28-JUN-2023, entry version 192.
DE   RecName: Full=N-acetyl-D-glucosamine kinase {ECO:0000305};
DE            Short=N-acetylglucosamine kinase {ECO:0000303|PubMed:10824116};
DE            EC=2.7.1.59 {ECO:0000269|PubMed:10824116, ECO:0000269|PubMed:22692205};
DE   AltName: Full=GlcNAc kinase;
DE   AltName: Full=Muramyl dipeptide kinase {ECO:0000305};
DE            EC=2.7.1.- {ECO:0000269|PubMed:36002575};
DE   AltName: Full=N-acetyl-D-mannosamine kinase {ECO:0000305};
DE            EC=2.7.1.60 {ECO:0000250|UniProtKB:Q9QZ08};
GN   Name=NAGK {ECO:0000303|PubMed:36002575, ECO:0000312|HGNC:HGNC:17174};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=10824116; DOI=10.1046/j.1432-1327.2000.01360.x;
RA   Hinderlich S., Berger M., Schwarzkopf M., Effertz K., Reutter W.;
RT   "Molecular cloning and characterization of murine and human N-
RT   acetylglucosamine kinase.";
RL   Eur. J. Biochem. 267:3301-3308(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS ARG-38 AND
RP   VAL-60.
RC   TISSUE=Kidney, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-14.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [9]
RP   PROTEIN SEQUENCE OF 245-261 AND 281-291, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [10]
RP   PHOSPHORYLATION AT TYR-205.
RX   PubMed=12112843;
RX   DOI=10.1002/1615-9861(200206)2:6<642::aid-prot642>3.0.co;2-i;
RA   Maguire P.B., Wynne K.J., Harney D.F., O'Donoghue N.M., Stephens G.,
RA   Fitzgerald D.J.;
RT   "Identification of the phosphotyrosine proteome from thrombin activated
RT   platelets.";
RL   Proteomics 2:642-648(2002).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=22692205; DOI=10.1074/jbc.m112.363549;
RA   Bergfeld A.K., Pearce O.M., Diaz S.L., Pham T., Varki A.;
RT   "Metabolism of vertebrate amino sugars with N-glycolyl groups: elucidating
RT   the intracellular fate of the non-human sialic acid N-glycolylneuraminic
RT   acid.";
RL   J. Biol. Chem. 287:28865-28881(2012).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF ASP-107.
RX   PubMed=36002575; DOI=10.1038/s41586-022-05125-x;
RA   Stafford C.A., Gassauer A.M., de Oliveira Mann C.C., Tanzer M.C.,
RA   Fessler E., Wefers B., Nagl D., Kuut G., Sulek K., Vasilopoulou C.,
RA   Schwojer S.J., Wiest A., Pfautsch M.K., Wurst W., Yabal M., Froehlich T.,
RA   Mann M., Gisch N., Jae L.T., Hornung V.;
RT   "Phosphorylation of muramyl peptides by NAGK is required for NOD2
RT   activation.";
RL   Nature 609:590-596(2022).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1-345 IN COMPLEXES WITH SUBSTRATE;
RP   GLUCOSE AND ADP, AND SUBUNIT.
RX   PubMed=17010375; DOI=10.1016/j.jmb.2006.08.085;
RA   Weihofen W.A., Berger M., Chen H., Saenger W., Hinderlich S.;
RT   "Structures of human N-acetylglucosamine kinase in two complexes with N-
RT   acetylglucosamine and with ADP/glucose: insights into substrate specificity
RT   and regulation.";
RL   J. Mol. Biol. 364:388-399(2006).
CC   -!- FUNCTION: Converts endogenous N-acetylglucosamine (GlcNAc), a major
CC       component of complex carbohydrates, from lysosomal degradation or
CC       nutritional sources into GlcNAc 6-phosphate (PubMed:22692205). Involved
CC       in the N-glycolylneuraminic acid (Neu5Gc) degradation pathway: although
CC       human is not able to catalyze formation of Neu5Gc due to the inactive
CC       CMAHP enzyme, Neu5Gc is present in food and must be degraded
CC       (PubMed:22692205). Also has N-acetylmannosamine (ManNAc) kinase
CC       activity (By similarity). Also involved in innate immunity by promoting
CC       detection of bacterial peptidoglycan by NOD2: acts by catalyzing
CC       phosphorylation of muramyl dipeptide (MDP), a fragment of bacterial
CC       peptidoglycan, to generate 6-O-phospho-muramyl dipeptide, which acts as
CC       a direct ligand for NOD2 (PubMed:36002575).
CC       {ECO:0000250|UniProtKB:Q9QZ08, ECO:0000269|PubMed:22692205,
CC       ECO:0000269|PubMed:36002575}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + N-acetyl-D-glucosamine = ADP + H(+) + N-acetyl-D-
CC         glucosamine 6-phosphate; Xref=Rhea:RHEA:17417, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:57513, ChEBI:CHEBI:456216,
CC         ChEBI:CHEBI:506227; EC=2.7.1.59;
CC         Evidence={ECO:0000269|PubMed:22692205};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17418;
CC         Evidence={ECO:0000269|PubMed:22692205};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + N-acetyl-D-mannosamine = ADP + H(+) + N-acetyl-D-
CC         mannosamine 6-phosphate; Xref=Rhea:RHEA:25253, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17122, ChEBI:CHEBI:30616, ChEBI:CHEBI:58557,
CC         ChEBI:CHEBI:456216; EC=2.7.1.60;
CC         Evidence={ECO:0000250|UniProtKB:Q9QZ08};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:25254;
CC         Evidence={ECO:0000250|UniProtKB:Q9QZ08};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + N-acetyl-D-muramoyl-L-alanyl-D-isoglutamine = 6-O-
CC         phospho-N-acetyl-D-muramoyl-L-alanyl-D-isoglutamine + ADP + H(+);
CC         Xref=Rhea:RHEA:75935, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:155830, ChEBI:CHEBI:194492, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:36002575};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75936;
CC         Evidence={ECO:0000269|PubMed:36002575};
CC   -!- PATHWAY: Amino-sugar metabolism; N-acetylneuraminate degradation.
CC       {ECO:0000269|PubMed:22692205}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:17010375}.
CC   -!- INTERACTION:
CC       Q9UJ70; Q9NZ32: ACTR10; NbExp=3; IntAct=EBI-372578, EBI-2559426;
CC       Q9UJ70; P42773: CDKN2C; NbExp=4; IntAct=EBI-372578, EBI-711290;
CC       Q9UJ70; Q9UI36: DACH1; NbExp=3; IntAct=EBI-372578, EBI-347111;
CC       Q9UJ70; Q9UI36-2: DACH1; NbExp=5; IntAct=EBI-372578, EBI-10186082;
CC       Q9UJ70; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-372578, EBI-739832;
CC       Q9UJ70; P50221: MEOX1; NbExp=3; IntAct=EBI-372578, EBI-2864512;
CC       Q9UJ70; Q04864: REL; NbExp=3; IntAct=EBI-372578, EBI-307352;
CC       Q9UJ70; O00560: SDCBP; NbExp=5; IntAct=EBI-372578, EBI-727004;
CC       Q9UJ70; Q99081: TCF12; NbExp=3; IntAct=EBI-372578, EBI-722877;
CC       Q9UJ70; B2R7W0; NbExp=3; IntAct=EBI-372578, EBI-10175537;
CC       Q9UJ70-2; Q15327: ANKRD1; NbExp=3; IntAct=EBI-11526455, EBI-5653378;
CC       Q9UJ70-2; P55212: CASP6; NbExp=3; IntAct=EBI-11526455, EBI-718729;
CC       Q9UJ70-2; P06307: CCK; NbExp=3; IntAct=EBI-11526455, EBI-6624398;
CC       Q9UJ70-2; P42773: CDKN2C; NbExp=3; IntAct=EBI-11526455, EBI-711290;
CC       Q9UJ70-2; Q9UI36-2: DACH1; NbExp=3; IntAct=EBI-11526455, EBI-10186082;
CC       Q9UJ70-2; P13473-2: LAMP2; NbExp=3; IntAct=EBI-11526455, EBI-21591415;
CC       Q9UJ70-2; P25800: LMO1; NbExp=5; IntAct=EBI-11526455, EBI-8639312;
CC       Q9UJ70-2; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-11526455, EBI-739832;
CC       Q9UJ70-2; P13995: MTHFD2; NbExp=3; IntAct=EBI-11526455, EBI-1058895;
CC       Q9UJ70-2; Q96HA8: NTAQ1; NbExp=5; IntAct=EBI-11526455, EBI-741158;
CC       Q9UJ70-2; O00560: SDCBP; NbExp=3; IntAct=EBI-11526455, EBI-727004;
CC       Q9UJ70-2; Q9Y371: SH3GLB1; NbExp=3; IntAct=EBI-11526455, EBI-2623095;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UJ70-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UJ70-2; Sequence=VSP_044586;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10824116}.
CC   -!- SIMILARITY: Belongs to the eukaryotic-type N-acetylglucosamine kinase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ242910; CAB61848.1; -; mRNA.
DR   EMBL; AK001812; BAA91923.1; -; mRNA.
DR   EMBL; AK297224; BAG59707.1; -; mRNA.
DR   EMBL; CR457271; CAG33552.1; -; mRNA.
DR   EMBL; AK222645; BAD96365.1; -; mRNA.
DR   EMBL; AC007881; AAY14748.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99780.1; -; Genomic_DNA.
DR   EMBL; BC001029; AAH01029.1; -; mRNA.
DR   EMBL; BC005371; AAH05371.1; -; mRNA.
DR   CCDS; CCDS33220.3; -. [Q9UJ70-1]
DR   RefSeq; NP_060037.3; NM_017567.4. [Q9UJ70-1]
DR   PDB; 2CH5; X-ray; 1.90 A; A/B/C/D=1-344.
DR   PDB; 2CH6; X-ray; 2.72 A; A/B/C/D=1-344.
DR   PDBsum; 2CH5; -.
DR   PDBsum; 2CH6; -.
DR   AlphaFoldDB; Q9UJ70; -.
DR   SMR; Q9UJ70; -.
DR   BioGRID; 120728; 181.
DR   IntAct; Q9UJ70; 75.
DR   MINT; Q9UJ70; -.
DR   STRING; 9606.ENSP00000477639; -.
DR   ChEMBL; CHEMBL4295978; -.
DR   DrugBank; DB00141; N-Acetylglucosamine.
DR   GlyGen; Q9UJ70; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UJ70; -.
DR   PhosphoSitePlus; Q9UJ70; -.
DR   SwissPalm; Q9UJ70; -.
DR   BioMuta; NAGK; -.
DR   DMDM; 24638065; -.
DR   OGP; Q9UJ70; -.
DR   CPTAC; CPTAC-242; -.
DR   CPTAC; CPTAC-243; -.
DR   EPD; Q9UJ70; -.
DR   jPOST; Q9UJ70; -.
DR   MassIVE; Q9UJ70; -.
DR   MaxQB; Q9UJ70; -.
DR   PaxDb; Q9UJ70; -.
DR   PeptideAtlas; Q9UJ70; -.
DR   ProteomicsDB; 84593; -. [Q9UJ70-1]
DR   Antibodypedia; 31185; 317 antibodies from 27 providers.
DR   DNASU; 55577; -.
DR   Ensembl; ENST00000244204.11; ENSP00000244204.5; ENSG00000124357.13. [Q9UJ70-1]
DR   Ensembl; ENST00000455662.6; ENSP00000389087.2; ENSG00000124357.13. [Q9UJ70-2]
DR   Ensembl; ENST00000613852.4; ENSP00000477639.1; ENSG00000124357.13. [Q9UJ70-2]
DR   GeneID; 55577; -.
DR   KEGG; hsa:55577; -.
DR   MANE-Select; ENST00000244204.11; ENSP00000244204.5; NM_017567.6; NP_060037.4.
DR   UCSC; uc002shp.4; human. [Q9UJ70-1]
DR   AGR; HGNC:17174; -.
DR   CTD; 55577; -.
DR   DisGeNET; 55577; -.
DR   GeneCards; NAGK; -.
DR   HGNC; HGNC:17174; NAGK.
DR   HPA; ENSG00000124357; Low tissue specificity.
DR   MIM; 606828; gene.
DR   neXtProt; NX_Q9UJ70; -.
DR   OpenTargets; ENSG00000124357; -.
DR   PharmGKB; PA31436; -.
DR   VEuPathDB; HostDB:ENSG00000124357; -.
DR   eggNOG; KOG1794; Eukaryota.
DR   GeneTree; ENSGT00510000047418; -.
DR   InParanoid; Q9UJ70; -.
DR   OrthoDB; 3030525at2759; -.
DR   PhylomeDB; Q9UJ70; -.
DR   TreeFam; TF314158; -.
DR   BRENDA; 2.7.1.59; 2681.
DR   PathwayCommons; Q9UJ70; -.
DR   Reactome; R-HSA-446210; Synthesis of UDP-N-acetyl-glucosamine.
DR   SABIO-RK; Q9UJ70; -.
DR   SignaLink; Q9UJ70; -.
DR   UniPathway; UPA00629; -.
DR   BioGRID-ORCS; 55577; 17 hits in 1161 CRISPR screens.
DR   ChiTaRS; NAGK; human.
DR   EvolutionaryTrace; Q9UJ70; -.
DR   GeneWiki; NAGK; -.
DR   GenomeRNAi; 55577; -.
DR   Pharos; Q9UJ70; Tbio.
DR   PRO; PR:Q9UJ70; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9UJ70; protein.
DR   Bgee; ENSG00000124357; Expressed in monocyte and 195 other tissues.
DR   ExpressionAtlas; Q9UJ70; baseline and differential.
DR   Genevisible; Q9UJ70; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0045127; F:N-acetylglucosamine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006044; P:N-acetylglucosamine metabolic process; TAS:ProtInc.
DR   GO; GO:0006051; P:N-acetylmannosamine metabolic process; TAS:ProtInc.
DR   GO; GO:0019262; P:N-acetylneuraminate catabolic process; TAS:UniProtKB.
DR   CDD; cd00012; NBD_sugar-kinase_HSP70_actin; 1.
DR   Gene3D; 3.30.420.40; -; 1.
DR   InterPro; IPR002731; ATPase_BadF.
DR   InterPro; IPR043129; ATPase_NBD.
DR   InterPro; IPR039758; NAGK_prok_euk.
DR   PANTHER; PTHR12862; BADF TYPE ATPASE DOMAIN-CONTAINING PROTEIN; 1.
DR   PANTHER; PTHR12862:SF0; N-ACETYL-D-GLUCOSAMINE KINASE; 1.
DR   Pfam; PF01869; BcrAD_BadFG; 1.
DR   SUPFAM; SSF53067; Actin-like ATPase domain; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Direct protein sequencing; Immunity; Innate immunity; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:12665801,
FT                   ECO:0007744|PubMed:22223895, ECO:0007744|PubMed:22814378"
FT   CHAIN           2..344
FT                   /note="N-acetyl-D-glucosamine kinase"
FT                   /id="PRO_0000096696"
FT   BINDING         13
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000305|PubMed:17010375,
FT                   ECO:0007744|PDB:2CH6"
FT   BINDING         36
FT                   /ligand="N-acetyl-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:506227"
FT                   /evidence="ECO:0000269|PubMed:17010375,
FT                   ECO:0007744|PDB:2CH5"
FT   BINDING         107
FT                   /ligand="N-acetyl-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:506227"
FT                   /evidence="ECO:0000269|PubMed:17010375,
FT                   ECO:0007744|PDB:2CH5"
FT   BINDING         127
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000305|PubMed:17010375,
FT                   ECO:0007744|PDB:2CH6"
FT   BINDING         129..130
FT                   /ligand="N-acetyl-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:506227"
FT                   /evidence="ECO:0000269|PubMed:17010375,
FT                   ECO:0007744|PDB:2CH5"
FT   BINDING         145..147
FT                   /ligand="N-acetyl-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:506227"
FT                   /evidence="ECO:0000269|PubMed:17010375,
FT                   ECO:0007744|PDB:2CH5"
FT   BINDING         152
FT                   /ligand="N-acetyl-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:506227"
FT                   /evidence="ECO:0000269|PubMed:17010375,
FT                   ECO:0007744|PDB:2CH5"
FT   BINDING         214
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000305|PubMed:17010375,
FT                   ECO:0007744|PDB:2CH6"
FT   BINDING         271
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000305|PubMed:17010375,
FT                   ECO:0007744|PDB:2CH6"
FT   BINDING         275
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000305|PubMed:17010375,
FT                   ECO:0007744|PDB:2CH6"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   MOD_RES         76
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         205
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:12112843"
FT   VAR_SEQ         1
FT                   /note="M -> MRTRTGSQLAAREVTGSGAVPRQLEGRRCQAGRDANGGTSSDGSSSM
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044586"
FT   VARIANT         38
FT                   /note="W -> R (in dbSNP:rs17856147)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_029763"
FT   VARIANT         60
FT                   /note="A -> V (in dbSNP:rs17849984)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_029764"
FT   MUTAGEN         107
FT                   /note="D->V: Abolished ability to phosphorylate muramyl
FT                   dipeptide."
FT                   /evidence="ECO:0000269|PubMed:36002575"
FT   CONFLICT        70
FT                   /note="S -> I (in Ref. 1; CAB61848)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        121
FT                   /note="V -> I (in Ref. 1; CAB61848)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        211
FT                   /note="C -> Y (in Ref. 4; BAD96365)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        286
FT                   /note="A -> V (in Ref. 2; BAA91923)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        324
FT                   /note="G -> R (in Ref. 2; BAA91923)"
FT                   /evidence="ECO:0000305"
FT   STRAND          4..10
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   STRAND          15..21
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   STRAND          26..32
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           37..40
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           42..60
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   STRAND          64..66
FT                   /evidence="ECO:0007829|PDB:2CH6"
FT   STRAND          68..75
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   TURN            76..79
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           81..94
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   STRAND          98..100
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   STRAND          102..106
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           107..115
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   STRAND          120..134
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   STRAND          136..138
FT                   /evidence="ECO:0007829|PDB:2CH6"
FT   STRAND          140..144
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   TURN            148..150
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           156..171
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           182..192
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           197..201
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   TURN            202..207
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           210..214
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           217..225
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           229..249
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           250..252
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           255..258
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   STRAND          259..262
FT                   /evidence="ECO:0007829|PDB:2CH6"
FT   STRAND          264..270
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           271..275
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           276..290
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   STRAND          300..309
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           312..321
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   TURN            322..324
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   HELIX           331..334
FT                   /evidence="ECO:0007829|PDB:2CH5"
FT   STRAND          335..342
FT                   /evidence="ECO:0007829|PDB:2CH5"
SQ   SEQUENCE   344 AA;  37376 MW;  FCBB6B328EF4D515 CRC64;
     MAAIYGGVEG GGTRSEVLLV SEDGKILAEA DGLSTNHWLI GTDKCVERIN EMVNRAKRKA
     GVDPLVPLRS LGLSLSGGDQ EDAGRILIEE LRDRFPYLSE SYLITTDAAG SIATATPDGG
     VVLISGTGSN CRLINPDGSE SGCGGWGHMM GDEGSAYWIA HQAVKIVFDS IDNLEAAPHD
     IGYVKQAMFH YFQVPDRLGI LTHLYRDFDK CRFAGFCRKI AEGAQQGDPL SRYIFRKAGE
     MLGRHIVAVL PEIDPVLFQG KIGLPILCVG SVWKSWELLK EGFLLALTQG REIQAQNFFS
     SFTLMKLRHS SALGGASLGA RHIGHLLPMD YSANAIAFYS YTFS
//
